首页> Immunotherapy> Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment

Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment

导出原文传递

翻译打印收藏纠错

第一作者： Shirota,H.

作者： Shirota,H. ^[1] ; Klinman,D.M. ^[2]

作者单位： Department of Clinical Oncology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai 980 ^[1] Cancer and Inflammation Program, National Cancer Institute, Frederick, MD 21702, United States ^[2]

关键词 cancer immunotherapy CpG oligonucleotide myeloid-derived suppressor cell Toll-like receptor 9

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Immunotherapy

2013年5卷8期

787-789页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Immunotherapy

2013年5卷8期

787-789页

检索历史清除

Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment

Immunotherapy

相似文献

同项目论文

Immunotherapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment

Immunotherapy

相似文献

同项目论文

Immunotherapy

相关期刊

检索历史清除